{"patient_id":"e34663e5-4dbf-482d-b8e6-1f7f7f991fc7","risk_assessment":{"summary":"Actionable PGx variants found in 1 gene(s).","overall_risk_score":40,"high_risk_variants_count":1},"pharmacogenomic_profile":[{"gene":"CYP2D6","variant":"rs3892097","genotype":"*4/*4","phenotype":"Poor Metabolizer","confidence":0.99},{"gene":"CYP2C19","variant":"rs12248560","genotype":"*1/*1","phenotype":"Normal Metabolizer","confidence":0.98},{"gene":"CYP2C9","variant":"rs1799853","genotype":"*1/*1","phenotype":"Normal Metabolizer","confidence":0.97},{"gene":"SLCO1B1","variant":"rs4149056","genotype":"*1/*1","phenotype":"Normal Metabolizer","confidence":0.96},{"gene":"DPYD","variant":"rs3918290","genotype":"*1/*1","phenotype":"Normal Metabolizer","confidence":0.99},{"gene":"TPMT","variant":"rs1142345","genotype":"*1/*1","phenotype":"Normal Metabolizer","confidence":0.99},{"gene":"VKORC1","variant":"rs9923231","genotype":"*1/*1","phenotype":"Normal Metabolizer","confidence":0.99},{"gene":"NUDT15","variant":"rs116855232","genotype":"*1/*1","phenotype":"Normal Metabolizer","confidence":0.99},{"gene":"CYP4F2","variant":"rs2108622","genotype":"*1/*1","phenotype":"Normal Metabolizer","confidence":0.97}],"clinical_recommendation":[{"drug":"Anthracyclines and related substances","action":"Avoid / Switch","reason":"CYP2D6 Poor Metabolizer detected. Follow standard protocol....","alternative":"See Clinical Pharmacist for Alternatives","evidence_level":"1A"},{"drug":"Clozapine","action":"Avoid / Switch","reason":"CYP2D6 Poor Metabolizer detected. There is no gene-drug interaction between CYP1A2 and clozapine.\n...","alternative":"See Clinical Pharmacist for Alternatives","evidence_level":"1A"},{"drug":"Valproic acid","action":"Avoid / Switch","reason":"CYP2D6 Poor Metabolizer detected. Follow standard protocol....","alternative":"See Clinical Pharmacist for Alternatives","evidence_level":"1A"},{"drug":"Antineoplastic agents","action":"Avoid / Switch","reason":"CYP2D6 Poor Metabolizer detected. Follow standard protocol....","alternative":"See Clinical Pharmacist for Alternatives","evidence_level":"1A"},{"drug":"Amisulpride","action":"Avoid / Switch","reason":"CYP2D6 Poor Metabolizer detected. Follow standard protocol....","alternative":"See Clinical Pharmacist for Alternatives","evidence_level":"1A"}],"llm_generated_explanation":{"biological_explanation":"Found significant metabolic variations in the CYP2D6 pathway(s). Specifically, the CYP2D6 gene is behaving as a Poor Metabolizer.","clinical_interpretation":"Based on processed PharmGKB and CPIC datasets, clinical actions are warranted for specific prodrugs or substances if relevant.","evidence_citation":"CPIC Guidelines v4.2; General; DPWG; CPIC; AHA; RNPGx; FDA/EMA Drug Labels 2026."},"quality_metrics":{"variant_evidence":"1A","annotation_quality":"High (ClinPGx Integrated)","database_certainty":"99.4%"}}